Reuters Health Report

Click to View in Browser 01/22/2014 FDA rejects Amarin appeal on Vascepa trial design, shares slump (Reuters) - Amarin Corp Plc's shares fell more than 26 percent after U.S. health regulators rejected a preset testing process that was critical to the company seeking broader use of its blood fat-lowering drug. FDA rejects wider use of Amag anemia drug; shares slide (Reuters) - Amag Pharmaceuticals Inc said the U.S. Food and Drug Administration rejected its application for wider use of its iron deficiency drug due to safety concerns and asked for more trial data. AstraZeneca's diabetes drug Xigduo approved in Europe LONDON (Reuters) - AstraZeneca said European regulators had approved Xigduo for type 2 diabetes, in what was the first green light for a fixed dose combination of a SGLT2 inhibitor and metformin. Danish government wants action against drug firms who prevent competition COPENHAGEN (Reuters) - Danish health minister Astrid Krag urged local government authorities to sue drug producers if they prevent competition in the pharmaceutical sector, business daily Jyllands-Posten said on Wednesday. Yellowstone managers reject vaccinating bison with biobullets (Reuters) - Yellowstone National Park managers have rejected a plan to use air rifles to shoot the nation's last herd of purebred bison with so-called biobullets containing a vaccine against a cattle disease, in a decision that has riled the U.S. livestock industry. Buzzed drivers under legal limit still risk car accidents NEW YORK (Reuters Health) - Even drivers with a slight "buzz" are more likely to be at fault for accidents than the sober drivers they hit, according to a new study. Mediterranean diet may be good for leg arteries, too NEW YORK (Reuters Health) - People who eat a Mediterranean diet high in olive oil or nuts may reduce their likelihood of developing clogged leg arteries, according to new research from Spain. Roche's schizophrenia drug misses goal in two late-stage trials ZURICH (Reuters) - An experimental Roche drug designed to treat the "negative symptoms" of schizophrenia failed to meet its main goal in two late-stage studies, dealing a blow to the Swiss drugmaker's research hopes in the risky area of brain science. Many hospitalized older people need decision help NEW YORK (Reuters Health) - When the time comes for making critical medical decisions while in the hospital, a new study says older people often rely on family members or other surrogates to make those calls. Colon surgery at busier hospitals may lead to better recovery NEW YORK (Reuters Health) - People who have colon surgery at high-volume hospitals are more likely than patients at smaller ones to go straight home for recovery without needing special care, according to a large new study. Related Video Stranded whales refloated in New Zealand Dolphin hunt in Japan's Taiji cove The latest Reuters articles on M&A, IPOs, private equity, hedge funds and regulatory updates delivered to your inbox each day. Register Today   A daily digest of breaking business news, coverage of the US economy, major corporate news and the financial markets. Register Today   » MORE NEWSLETTERS

- 3 Times Square New York, NY 10036 USA © Copyright 2010 Thomson Reuters Ensure delivery of Reuters Newsmails, add mail@nl.reuters.com to your address book. Details Subscribe to other Reuters newsletters. Unsubscribe from this newsletter. Follow us on Twitter Friend us on Facebook Forward to a friend